Dr Uli Hacksell (1950) has over 20 years of international management experience from both large pharmaceutical and biotech companies. He has served as CEO at two NASDAQ-listed biopharmaceutical companies, Cerecor (2016–2017) and ACADIA Pharmaceuticals (2000–2015), and led ACADIA from a private start-up to becoming a public multibillion dollar company.

Acadia Pharmaceuticals Inc. är ett biofarmaceutiskt företag med Han efterträddes av Uli Hacksell, som lämnade Acadia för att leda Cerecor i

Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies. 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

Uli hacksell acadia pharmaceuticals

Titel: Ledamot sedan 2018. Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2014 Results Earnings Conference Call May 6, 2014 5:00 PM ET Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - CEO. Roger G Net Worth and Insider Trades.

Styrelseledamot.

2021-04-07

Moore reports to ACADIA’s Chief Executive Officer, Uli Hacksell, Ph.D., and will be responsible for leading ACADIA’s commercial activities. “Terry is an exceptional individual who brings a wealth of commercial experience to ACADIA from a variety of senior roles at several leading pharmaceutical companies. AcAdiA PhArmAceuticAls | 2013 AnnuAl rePort 1 Uli Hacksell, Ph.D. Chief Executive Officer Q. For ACADIA, 2013 was a transformational year.

ACADIA also announced that Alan G. Walton, Senior General Partner of Oxford Bioscience Partners and Chairman of Oxford Bioscience Corporation, will join its board of directors. "We are delighted to complete this financing with such an outstanding syndicate of investors," said Uli Hacksell, Ph.D., ACADIA's Chief Executive Officer.

LinkedIn is the world’s largest business network, helping professionals like Kim Cardenas discover inside connections to recommended job Top executives at ACADIA Pharmaceuticals received an average of $567K per person in annual compensation from 2006 Uli HacksellChief Executive Officer. Affiliation. 1 ACADIA Pharmaceuticals Inc., 11085 Torreyana Road, Ste. 100, San Diego, CA, 92121, USA, uli@acadia-pharm.com.

“Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Som vd för ACADIA Pharmaceuticals 2000-2015 ledde Hacksell utvecklingen från privat start-up företag till publikt mångmiljardbolag. Innehade under 90-talet ledande befattningar inom Astra AB. Var dessförinnan professor i organisk kemi vid Uppsala universitet.

Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $67,800 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0.Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. The estimated Net Worth of Uli Hacksell is at least $84.6 mil dollars as of 10 December 2016.
Investera i aktier 2021

4 Sep 2014 Therapy designation to Acadia Pharmaceuticals' Nuplazid (Pimavanserin) for disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia.

Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter.

ACADIA Pharmaceuticals (NASDAQ:ACAD) Q4 2013 Earnings Call February 27, 2014 5:00 PM ET. Executives. Lisa Barthelemy - Director of Investor Relations. Uli Hacksell - Chief Executive Officer

Han var verkställande direktör för ACADIA Pharmaceuticals 2000 - 2015 och ledde företaget från att vara ett privat startföretag till att SAN DIEGO -- (BUSINESS WIRE)--Mar. 11, 2015-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders, today announced that Uli Hacksell, Ph.D., has retired as ACADIA’s Chief Executive Officer and as a member of the Board of Directors, effective today. Uli Hacksell CEO at ACADIA Pharmaceuticals Greater San Diego Area 354 connections. Join to Connect. ACADIA Pharmaceuticals. Report this profile; Experience. CEO ACADIA Pharmaceuticals.

Based on CEO Uli Hacksell's Shareholders of SynAct Pharma proposes Uli Hacksell as new board member US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Få den seneste information om ACADIA PHARMACEUTICALS A/S. Se regnskaber, Uli Alf Hacksell stopper som administrerende direktør for ACADIA 6 Nov 2013 "We remain focused on building value in our pimavanserin franchise and advancing our pipeline," said Uli Hacksell, Ph.D., ACADIA's Chief Roxanne Jividen is the Division President at Acadia Healthcare Company based in Acadia Pharmaceuticals CEO Uli Hacksell speaks at the Jefferies 2013 7 apr 2021 Uli Hacksells CV inkluderar 30 års arbete inom farmaceutisk industri och däribland som vd för San Diego-baserade Acadia Pharmaceuticals. Uli Hacksell har styrelseuppdrag i Medivir, Index Pharmaceuticals Holding, .. 4 Sep 2014 Therapy designation to Acadia Pharmaceuticals' Nuplazid (Pimavanserin) for disease psychosis,” said Uli Hacksell, Ph.D., CEO of Acadia. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the New targets and drug discovery – Uli Hacksell, Marina Biotech, Inc. Abstract CEO of ACADIA Pharmaceuticals from 2000-2015 where he was leading the. The stock of ACADIA Pharmaceuticals (NAS:ACAD, 30-year Financials) shows He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the ACADIA Pharmaceuticals has an analyst consensus of Strong Buy, with a price He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the Dr. Uli Hacksell, Chief Executive Officer of Acadia, said in a 2014 press release 4.